2[1]Henz.The phannacologic profile of desloraLadine:a review[J].Allergy,2001,56(1):7-13.
3[2]Barechi ME,Casciano CN,John WW,el al Lnvitro characterization of the inhibition profile of loratadinc[J]Drug Metab Dispos,2001,29(9):1173-1175.
4Umetsu DT,Dekruyff RH.TH1 and TH2 CD4^+ cells in human allergic diseases[J].J Allergy Clin Immunol,1997,100(1):1 -6.
5PrakashA,Lamb HM.Mizoiastine:a review of its use in allergic rhinitis and chronic idiopathic urticaria[J].Biodrug,1998,10 (1):42.
6Sudo K,Nagai K,Yamada N.Inhibitory effects of mizolastine on 5 lipoxyenase[J].Japan Pharmacol Ther,1998,26 (1):155.
7Yamad N,Funayama K.Inhibitory effects of mizolastine on the release of mediators and antagonistic effects against mediators[J].Japan Pharmacol Ther,1998,26 (1):131.
8Grattan CEH et al. Clinical and Experimental Allergy . 1992
9Fiebiger E et al. The Journal of Clinical Investigation . 1998
10Hide M et al. The New England Journal of Medicine . 1993
